Regulatory PathRegulatory requirements compared

Active substance

Propoxyphene

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
DARVON32MG; 65MGcapsule · oralXANODYNE PHARMDiscontinued16 Aug 1957
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralPAR PHARMDiscontinued30 Nov 1971
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralWATSON LABSDiscontinued7 Aug 1972
DOLENE65MGcapsule · oralHERITAGE PHARMS INCDiscontinued15 Sep 1972
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralSANDOZDiscontinued18 Oct 1972
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralNEXGEN PHARMA INCDiscontinued2 Nov 1972
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralMUTUAL PHARMDiscontinued18 Dec 1972
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralPUREPAC PHARMDiscontinued15 Jan 1973
KESSO-GESIC65MGcapsule · oralMK LABSDiscontinued6 Jun 1973
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralWEST WARDDiscontinued20 Jun 1973
PROPOXYPHENE HYDROCHLORIDE32MG; 65MGcapsule · oralROXANEDiscontinued13 Aug 1973
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralIMPAX LABSDiscontinued23 Oct 1973
PROPOXYPHENE HYDROCHLORIDE32MGcapsule · oralIVAX SUB TEVA PHARMSDiscontinued11 Dec 1973
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralSANDOZDiscontinued27 Aug 1974
PROPOXYPHENE HYDROCHLORIDE32MGcapsule · oralSANDOZDiscontinued9 Sep 1974
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralSANDOZDiscontinued13 Feb 1975
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralPVT FORMDiscontinued20 Aug 1976
PROPOXYPHENE HYDROCHLORIDE32MGcapsule · oralPVT FORMDiscontinued20 Aug 1976
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralWATSON LABSDiscontinued8 Nov 1976
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralSANDOZDiscontinued7 Jul 1980
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralTEVADiscontinued22 Oct 1984
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralMYLANDiscontinued16 Dec 2004
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralVINTAGE PHARMSDiscontinued17 Jul 2009
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralVALEANT PHARM INTLDiscontinued
PROPOXYPHENE HYDROCHLORIDE65MGcapsule · oralALRADiscontinued

5 more — full table

Safety signals and safety-related labeling changes

  • MHRA 11 Dec 2014 (Dextro)propoxyphene: new studies confirm cardiac risks
    (Dextro)propoxyphene can have serious effects on the electrical activity of the heart (resulting in prolongation of the P-R and Q-T intervals, and widened QRS complexes), even at normal therapeutic doses.

All safety entries for propoxyphene →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.